Navigation Links
Clinical Care Options Launches CCO HIV inPractice, a Unique, Free, Comprehensive Online Resource for Healthcare Providers at the Point of Care
Date:10/28/2009

RESTON, Va., Oct. 28 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative online, print, and live medical education programs and medical education technologies for healthcare professionals, announced the launch of CCO HIV inPractice, a new, free, online point-of-care resource for clinicians that provides critical information for the management of HIV/AIDS.

"CCO HIV inPractice will empower clinicians at the point of care to improve patient care by expanding access to the latest and highest-quality management information," said Jeffrey L. Drezner, MD, Ph.D., CEO of CCO. "In addition to searching the comprehensive reference content that has been developed specifically for inPractice as well as 5 additional databases, CCO inPractice users will be able to earn Point of Care CME credits, receive personalized recommendations for complementary CCO continuing education activities, and access links to other resources and interactive tools."

CCO HIV inPractice, authored by world-renowned experts, provides a single easy-to-use search tool to explore 42 original chapters designed specifically for point-of-care use, integrated with drug information, treatment guidelines, conference coverage, and PubMed abstracts. The Editors in Chief of CCO HIV inPractice, Joseph J. Eron, Jr., MD, of the University of North Carolina; Kimberly Y. Smith, MD, MPH, of Rush University; and Kathleen E. Squires, MD, of Thomas Jefferson University, have guided the development of content by 59 authors and will continue to oversee regular updates to this dynamic program found at www.inpractice.com.

"The CCO team, pioneers in online HIV education for more than 20 years, has produced a remarkable resource to support those of us providing direct care in the clinic," said Kimberly Y. Smith, MD, MPH. "I am proud to be associated with this truly innovative point-of-care resource with its state-of-the-art content and technology. CCO HIV inPractice will be an essential resource for all clinicians looking for answers to their HIV management questions in the clinic setting."

CCO HIV inPractice is certified for Point of Care CME credit by USF Health. The CCO inPractice program is supported by independent medical education grants provided by commercial supporters.

For more information about CCO inPractice, visit www.inpractice.com or email memberservices@clinicaloptions.com.

About Clinical Care Options

Clinical Care Options, a leader in the development of innovative, interactive, online medical education programs and proprietary medical education technologies for healthcare professionals, creates and publishes original continuing medical education and information resources that are designed specifically for healthcare providers in the areas of HIV, hepatitis/gastroenterology, and oncology. CCO's educational programs are developed not only to provide the latest scientific information but also to support the understanding, confidence, application, and competence of healthcare professional learners. In addition to the latest point-of-care resource, inPractice, CCO provides a spectrum of live and online educational programs and formats. For more information about the company and its programs, visit www.clinicaloptions.com.

SOURCE Clinical Care Options


'/>"/>
SOURCE Clinical Care Options
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New clinical guidelines for exacerbations in cystic fibrosis
2. AAAS and partners debut new online networks for clinical and minority scientists
3. Halifax Regional Medical Center Selects Micromedex Solutions from Thomson Reuters for Clinical Decision Support
4. Vascular Study Group of New England Selects Clinical Data Pathways, Powered by M2S, as Quality Improvement Registry Provider
5. PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum
6. Wound Management Technologies Announces Clinical Study Presentation of CellerateRx(R) Technology at Leading Skin and Wound Care Conference
7. DATATRAK Exhibiting at the DIAs 3rd Annual Clinical Forum in Nice, France
8. SRI International Awarded a Department of Defense Laboratory-Clinical Transition Grant to Advance SRIs Novel Anticancer Agents for Prostate Cancer Treatment
9. Rest Assured With Clinically Tested Anti-Snore Pillow
10. Preventing Fungal Infections in HSCT Recipients: Insights from Clinical Cases
11. NIH announces expansion of Rare Diseases Clinical Research Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 30, 2017 , ... Grass pollen is the main cause of hay fever in the United ... for grass pollen runs from May to July each year; with the worst time for ... HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they ...
(Date:3/29/2017)... ... ... Brand EXOUS Bodygear announced today a special sale price for the EX-701 Knee ... the price will be only $19.97. The EXOUS Bodygear 65cm exercise ball ... $19.97). , The special promotional prices are to help individuals get their products at ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Minn. (PRWEB) , ... March 29, 2017 , ... ... medical office buildings (MOBs) and other outpatient facilities, and who are the most ... exclusively at those questions, Revista and Healthcare Real Estate Insights (HREI) found that ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important webinar ... at 1:00 PM ET. A recording of the webinar will also be made available ... Home health and hospice companies are still popular targets for healthcare investors. This highly ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... 29, 2017  Maxor National Pharmacy Services, LLC ("Maxor"), ... has named Leah Bailey as General Counsel.  Bailey ... the company. With more than 13 years ... years focused on health care, Bailey joins the Maxor ... Prime, Bailey advised the PBM, Specialty, and Mail Order ...
(Date:3/29/2017)... Varian Medical Systems (NYSE: VAR ) ... quarter of fiscal year 2017 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ... call and replay: ...
Breaking Medicine Technology: